MarketPulse
S

$STAA

3 articles found
2 positive
0 negative
1 neutral
BenzingaBenzinga··Mohd Haider

STAAR Surgical Soars 20% on $90M Q1 Sales, Powered by China and Americas Growth

STAAR Surgical surges 20% after-hours on $90M Q1 sales, more than double year-ago quarter, driven by China and Americas growth despite regional headwinds.
STAAearningsrevenue growth
BenzingaBenzinga··Vandana Singh

Alcon Terminates LENSAR Merger After FTC Delays Tank Stock 25%

Alcon terminates $14/share LENSAR merger after FTC regulatory delays. LENSAR stock crashes 25.44% to 52-week low of $7.65, destroying shareholder value.
ALCLNSRSTAAstock declineregulatory review
BenzingaBenzinga··Vandana Singh

Staar Surgical Wins FDA Clearance to Expand Implantable Lens Market to Older Patients

Staar Surgical wins FDA approval to expand implantable lens eligibility to patients aged 21-60, up from 21-45, potentially reaching 8 million additional U.S. candidates.
ALCSTAAXHEFDA approvaltechnical analysis